ENDEAVOR: A phase 3 study of carfilzomib and dexamethasone versus bortezomib and dexamethasone in patients with relapsed multiple myeloma | Dr Jesús San Miguel at EHA 2015

At the 20th Congress of the European Hematology Association (EHA), Jesús F. San Miguel, MD, of the Clínica Universidad de Navarra, Navarra, Spain, discusses the results of the multicentre, open-label,... Author: EMJ Added: 06/25/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts